Table 1 Major clinicopathological characteristics of PMP patients between STS and LTS groups
From: Long-term survival in patients with PMP: a single-institutional retrospective study from China
Variable | STS group (n = 162) | LTS group (n = 39) | p-value |
|---|---|---|---|
Gender, n (%) | 0.006 | ||
Male | 94 (58.0) | 13 (33.3) | |
Female | 68 (42.0) | 26 (66.7) | |
Age (years), median (range) | 56 (24–79) | 56 (34–73) | 0.750 |
Intravenous chemotherapy, n (%) | 0.038 | ||
No | 78 (48.1) | 26 (66.7) | |
Yes | 84 (51.9) | 13 (33.3) | |
Previous surgical score, n (%) | 0.016 | ||
0–1 | 53 (32.7) | 21 (53.8) | |
2–3 | 107 (66.0) | 18 (46.2) | |
NA | 2 (1.2) | ||
KPS, n (%) | 0.040 | ||
≥ 80 | 112 (69.1) | 34 (87.2) | |
< 80 | 28 (17.3) | 2 (5.1) | |
NA | 22 (13.6) | 3 (7.7) | |
Pathological diagnosis, n (%) | 0.000 | ||
Low grade | 56 (34.6) | 25 (64.1) | |
High grade | 59 (36.4) | 11 (28.2) | |
High grade with signet ring cells | 41 (25.3) | 1 (2.6) | |
NA | 6 (3.7) | 2 (5.1) | |
Vascular invasion, n (%) | 0.096 | ||
No | 143 (88.3) | 39 (100.0) | |
Yes | 15 (9.3) | 0 (0.0) | |
NA | 4 (2.5) | 0 (0.0) | |
Lymphatic metastasis, n (%) | 0.048 | ||
No | 139 (90.5) | 39 (100.0) | |
Yes | 19 (7.5) | 0 (0.0) | |
NA | 4 (1.9) | 0 (0.0) |